#Banknifty Expiry Levels for 10-08-2023#Banknifty Expiry Levels for 10-08-2023
> If you're following these zones then kindly follow the rules too. Risk management, Position sizing, and Rules.
> This is my perception of the market so, kindly do your analysis to get more clarity on the market.
> These levels might help you guys. As per my view, I'm sharing it with you guys.
> This is not a blueprint to happen so, kindly do your own analysis along with my view. Thank you for your SUPPORT.
Stockmaket
CHOT.N0000Wait for pullback to 16 - 17
Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
$BLDEBlade Air Mobility Inc has fallen Monday morning, with the stock decreasing -5.24% in pre-market trading to 10.66.
BLDE's short-term technical score of 20 indicates that the stock has traded less bullishly over the last month than 80% of stocks on the market.
In the Airports & Air Services industry, which ranks 47 out of 146 industries.
BLDE ranks higher than 23% of stocks.
Blade Air Mobility Inc has risen 55.60% over the past month, closing at $7.66 on August 23.
During this period of time, the stock fell as low as $7.66 and as high as $11.25. BLDE has an average analyst recommendation of Strong Buy.
The company has an average price target of $15.67.
When we look at the technical side of things we can see it’s broken above resistance and even with yesterday’s markets fall it was still able to stay above resistance.
We could say previous resistance is now acting as support on the lower timeframes.
We have the MACD sitting comfortably above 0.50 and the RSI above 50.
I’m fairly bullish on this.
Keep this on your watchlist.
- Factor Four
MLNT - Bullish Buying - Could Bounce The DropMelinta Therapeutics, Inc. operates as a commercial-stage pharmaceutical company which engages in developing and commercializing anti-infective s for the hospital and selected non-hospital or communities. It markets antibiotics including Baxdela, Vabomere, Orbactiv, and Minocin for injections. These antibiotics are used in the treatment of infections caused by various bacterial diseases. The company was founded by William L. Jorgensen, Peter Moore, and Thomas A. Steitz in October 2000 is headquartered in Morristown, NJ.
SHORT INTEREST
894.4K 08/15/19
P/E Current
-0.13
P/E Ratio (with extraordinary items)
-0.20
Average Recommendation: HOLD
Average Target Price: 12.00